Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Explore the critical relationship between autoantibodies and clinical phenotypes in Idiopathic Inflammatory Myopathies (IIMs) through this comprehensive 46-minute webinar. Learn how different autoantibodies appearing in myositis patients correlate with specific clinical characteristics and pathological findings in muscular biopsies. Discover how clinicians can identify distinct myositis subtypes including dermatomyositis, immune-mediated necrotizing myopathy, antisynthetase syndrome, polymyositis, and sporadic inclusion body myositis by analyzing autoantibody types alongside muscle pathology, capillaroscopy data, and systemic manifestations. Understand the clinical significance of specific autoantibody associations, such as anti-MDA5 with rapidly progressive interstitial lung disease, anti-Mi2 with severe skin disease but favorable prognosis, and anti-TIF1γ with high cancer association rates. Gain insights into how autoantibody detection guides optimal diagnostic and therapeutic strategies for individual patients, as each clinical presentation carries different implications for treatment approaches. The session is presented by Prof. Albert Selva O'Callaghan from Vall d'Hebron General Hospital, Barcelona, a leading expert with over 25 years of experience in idiopathic inflammatory myopathy research and clinical practice, and moderated by Prof. Patricia E Carreira from University Hospital 12 de Octubre, Madrid.
